Arthritis Innovation Corporation
  • About Us
  • Technology
  • More
    • About Us
    • Technology
Arthritis Innovation Corporation
  • About Us
  • Technology

Arthritis Innovation Corporation (AIC) is a clinical-stage pharmaceutical company addressing unmet needs in orthopedic surgery and arthritis management.   


A private company founded in 2013, AIC leverages a world-class product development team located in Toronto, Canada and Denver, Colorado, and a proprietary polymer drug delivery system (BEPO®) formulated with previously marketed drugs. 


AIC's first drug in clinical development brings sustained, local delivery of a well-known NSAID for the management of pain and inflammation after total knee replacement (TKR) surgery, as an alternative to narcotics or oral NSAIDs. 

                                                                                                                                                                

Completed Phase 2 Study: Clinicaltrials.gov: NCT03541655.   For more information, click HERE.

Upcoming Phase 3 Safety Arm:  Clinicaltrials.gov: NCT04860635.  For more information, click HERE.

Copyright © 2021 Arthritis Innovation Corporation - All Rights Reserved.

Powered by GoDaddy

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept